Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential

Sridhar Vempati, Carola Reindl, Seshu Kumar Kaza, Ruth Kern, Theodora Malamoussi, Martin Dugas, Gudrun Mellert, Susanne Schnittger, Wolfgang Hiddemann, Karsten Spiekermann

Blood (2007) 110 (2): 686–694.

https://doi.org/10.1182/blood-2006-10-053181

Published: 2007

Journal Articles

The JAK2-V617F Mutant Found in Myeloproliferative Disorders and Acute Myeloid Leukemia Cooperates with the EpoR, but Not with FLT3 To Promote Proliferation of IL-3 Dependent Cells.

Seshu K. Kaza, Sridhar Vempati, Reindl Carola, Wolfgang Hiddemann, Karsten Spiekermann

Blood (2006) 108 (11): 1935.

https://doi.org/10.1182/blood.V108.11.1935.1935

Published: 2006

Journal Articles

Oncogenic CBL Mutants Have Transforming Potential in Cells Expressing the FLT3 Tyrosine Kinase.

Carola Reindl, Sridhar Vempati, Hilmar Quentmeier, Gudrun Mellert, Wolfgang Hiddemann, Karsten Spiekermann

Blood (2006) 108 (11): 1446.

https://doi.org/10.1182/blood.V108.11.1446.1446

Published: 2006

Journal Articles

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Carola Reindl, Ksenia Bagrintseva, Sridhar Vempati, Susanne Schnittger, Joachim W. Ellwart, Katja Wenig, Karl-Peter Hopfner, Wolfgang Hiddemann, Karsten Spiekermann

Blood (2006) 107 (9): 3700–3707.

https://doi.org/10.1182/blood-2005-06-2596

Published: 2006

Journal Articles

Arginine (R) at Position 595 in FLT3 Is Critical for Transforming Potential of FLT3-Length Mutations.

Sridhar Vempati, MSc, Ruth Schwab, Theodora Malamoussi, Martin Dugas, MD, Gudrun Mellert, Susanne Schnittger, PhD, Wolfgang Hiddemann, MD, PhD, Karsten Spiekermann, MD

Blood (2005) 106 (11): 1598.

https://doi.org/10.1182/blood.V106.11.1598.1598

Published: 2005

NARROW

Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential

The JAK2-V617F Mutant Found in Myeloproliferative Disorders and Acute Myeloid Leukemia Cooperates with the EpoR, but Not with FLT3 To Promote Proliferation of IL-3 Dependent Cells.

Oncogenic CBL Mutants Have Transforming Potential in Cells Expressing the FLT3 Tyrosine Kinase.

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Arginine (R) at Position 595 in FLT3 Is Critical for Transforming Potential of FLT3-Length Mutations.

Email alerts

ASH Publications

American Society of Hematology

Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential

The JAK2-V617F Mutant Found in Myeloproliferative Disorders and Acute Myeloid Leukemia Cooperates with the EpoR, but Not with FLT3 To Promote Proliferation of IL-3 Dependent Cells.

Oncogenic CBL Mutants Have Transforming Potential in Cells Expressing the FLT3 Tyrosine Kinase.

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Arginine (R) at Position 595 in FLT3 Is Critical for Transforming Potential of FLT3-Length Mutations.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only